May 16, 2019
…HIV, infectious disease and vaccines as focal points for global public health initiatives, but in many cases, the biggest bang for your buck is safe surgical care,” Gosman said. Congenital defects like cleft palate, motor vehicle injuries, burns—these are all situations in which surgical care can be transformative to otherwise…
March 21, 2022
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
May 16, 2016
Injections of the soil bacterium Mycobacterium vaccae promote stress resilience and improve coping behaviors in mice, according to a new study led by researchers at University of California San Diego School of Medicine and University of Colorado Boulder. The researchers also found that
December 18, 2020
…front lines of COVID-19 vaccine research Rommie Amaro, Professor of Chemistry and Biochemistry, University of California San Diego. From the start of the pandemic, the university has taken a lead in not only treating patients with COVID-19, but in advancing research on the virus and conducting clinical trials of vaccine…
April 30, 2018
By stretching the amount of time proteins can be simulated in their natural state of wiggling and gyrating, a team of researchers at Colorado State University— using supercomputers at the San Diego Supercomputer Center at UC San Diego and the Pittsburgh Supercomputing Center—has identified a critical protein structure that could…
September 30, 2021
…strategy that involves masking, vaccination, testing, environmental monitoring and contact tracing, has set a strong foundation for a successful fall quarter.” Return to Learn Positive case rates on campus have remained consistently low compared to regional and national case rates. As a result, UC San Diego has been able to…
October 31, 2023
Matthew and Iris Strauss and the Strauss Family Foundation have donated a world-class collection of contemporary art to the University of California San Diego. The collection is comprised of more than 100 pieces by artists from around the globe.
October 30, 2023
UC San Diego engineers have developed modular nanoparticles that can be easily customized to target different biological entities such as tumors, viruses or toxins. The nanoparticles can be tailored for various applications, ranging from targeted drug delivery to neutralizing biological agents.
January 16, 2020
An international team of scientists has synthetically engineered mosquitoes that halt the transmission of the dengue virus. The development marks the first engineered approach in mosquitoes that targets the four known types of dengue, improving upon previous designs that addressed single strains.
August 2, 2021
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
